Tissue factor pathway of coagulation in sepsis

被引:36
作者
Hack, CE
机构
[1] Netherlands Red Cross, Blood Transfus Serv, Cent Lab, NL-1066 CX Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Acad Hosp, Dept Clin Chem, Amsterdam, Netherlands
关键词
coagulation; inflammation; tissue factor pathway; sepsis; animals; humans;
D O I
10.1097/00003246-200009001-00006
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To review the role of the tissue factor pathway of coagulation in experimental sepsis. Data sources: Studies published in biomedical journals. Study selection: Studies on the role of the tissue factor pathway in animal or human models for sepsis. Data extraction and synthesis: Variables reflecting tissue factor pathway activation in the various models are discussed; the effects of administration of tissue factor pathway inhibitors on these and inflammatory variables, as well as on the course and outcome, are analyzed. Conclusion: Activation of coagulation during experimental sepsis occurs mainly, if not exclusively, via the tissue factor pathway; inhibitors of this pathway improve mortality, presumably by a combined attenuating effect on coagulative and inflammatory responses.
引用
收藏
页码:S25 / S30
页数:6
相关论文
共 64 条
[1]   INTERLEUKIN-2 INDUCES ACTIVATION OF COAGULATION AND FIBRINOLYSIS - RESEMBLANCE TO THE CHANGES SEEN DURING EXPERIMENTAL ENDOTOXEMIA [J].
BAARS, JW ;
DEBOER, JP ;
WAGSTAFF, J ;
ROEM, D ;
EERENBERGBELMER, AJM ;
NAUTA, J ;
PINEDO, HM ;
HACK, CE .
BRITISH JOURNAL OF HAEMATOLOGY, 1992, 82 (02) :295-301
[2]   DIVERGENT EFFICACY OF ANTIBODY TO TUMOR-NECROSIS-FACTOR-ALPHA IN INTRAVASCULAR AND PERITONITIS MODELS OF SEPSIS [J].
BAGBY, GJ ;
PLESSALA, KJ ;
WILSON, LA ;
THOMPSON, JJ ;
NELSON, S .
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (01) :83-88
[3]   RECOMBINANT TUMOR-NECROSIS-FACTOR INDUCES PROCOAGULANT ACTIVITY IN CULTURED HUMAN VASCULAR ENDOTHELIUM - CHARACTERIZATION AND COMPARISON WITH THE ACTIONS OF INTERLEUKIN-1 [J].
BEVILACQUA, MP ;
POBER, JS ;
MAJEAU, GR ;
FIERS, W ;
COTRAN, RS ;
GIMBRONE, MA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (12) :4533-4537
[4]   INTERLEUKIN-1 (IL-1) INDUCES BIOSYNTHESIS AND CELL-SURFACE EXPRESSION OF PROCOAGULANT ACTIVITY IN HUMAN VASCULAR ENDOTHELIAL-CELLS [J].
BEVILACQUA, MP ;
POBER, JS ;
MAJEAU, GR ;
COTRAN, RS ;
GIMBRONE, MA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 160 (02) :618-623
[5]  
BIEMOND BJ, 1995, THROMB HAEMOSTASIS, V73, P223
[6]  
BORNE PAV, 1997, J CLIN INVEST, V99, P2323
[7]   THE EFFECT OF 2-DOMAIN TISSUE FACTOR PATHWAY INHIBITOR ON ENDOTOXIN-INDUCED DISSEMINATED INTRAVASCULAR COAGULATION IN RABBITS [J].
BREGENGARD, C ;
NORDFANG, O ;
WILDGOOSE, P ;
SVENDSEN, O ;
HEDNER, U ;
DINESS, V .
BLOOD COAGULATION & FIBRINOLYSIS, 1993, 4 (05) :699-706
[8]   INTERLEUKIN 1-INDUCED PATHO-PHYSIOLOGY - INDUCTION OF CYTOKINES, DEVELOPMENT OF HISTOPATHOLOGIC CHANGES, AND IMMUNOPHARMACOLOGIC INTERVENTION [J].
BUTLER, LD ;
LAYMAN, NK ;
CAIN, RL ;
RIEDL, PE ;
MOHLER, KM ;
BOBBITT, JL ;
BELAGAJIE, R ;
SHARP, J ;
BENDELE, AM .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1989, 53 (03) :400-421
[9]   Delayed treatment with recombinant human tissue factor pathway inhibitor improves survival in rabbits with gram-negative peritonitis [J].
Camerota, AJ ;
Creasey, AA ;
Patla, V ;
Larkin, AA ;
Fink, MP .
JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (03) :668-676
[10]  
CARR C, 1994, CIRC SHOCK, V44, P126